CorMedix (CRMD) Operating Expenses (2010 - 2025)

CorMedix (CRMD) has 15 years of Operating Expenses data on file, last reported at $48.2 million in Q4 2025.

• For the quarter ending Q4 2025, Operating Expenses rose 181.79% year-over-year to $48.2 million; the trailing twelve-month figure through Dec 2025 stood at $125.6 million (up 100.53% YoY), and the FY2025 full-year result was $125.6 million, up 100.53% from the prior year.
• Operating Expenses improved to $48.2 million in Q4 2025, from $41.7 million in the prior quarter.
• In the past five years, Operating Expenses ranged from a high of $48.2 million in Q4 2025 to a low of $5.9 million in Q2 2021.
• A 5-year average of $14.9 million and a median of $11.4 million in 2023 frame the typical range for Operating Expenses.
• Across the five-year window, Operating Expenses slumped 34.11% in 2021 and surged 196.9% in 2025, its largest moves.
• Tracing CRMD's Operating Expenses over 5 years: stood at $7.8 million in 2021, then increased by 8.09% to $8.4 million in 2022, then soared by 86.12% to $15.7 million in 2023, then rose by 9.12% to $17.1 million in 2024, then surged by 181.79% to $48.2 million in 2025.
• Business Quant data shows CRMD's Operating Expenses at $48.2 million in Q4 2025, $41.7 million in Q3 2025, and $18.3 million in Q2 2025.